Cholecystectomy-related gut microbiota dysbiosis exacerbates colorectal tumorigenesis.
Bo Tang, Shengpeng Li, Xin Li...
https://pubmed.ncbi.nlm.nih.gov/40819131/Actively Recruiting
Led by Tongji Hospital · Updated on 2026-02-27
20
Participants Needed
1
Research Sites
N/A
Total Duration
This research aims to explore how polyethylene glycol PEG laxatives used for bowel preparation affect the gut microbiota in people who have had their gallbladder removed cholecystectomy. Both cholecystectomy and high doses of PEG are known to change the intestinal microbial balance, but it is unclear if those without a gallbladder experience more lasting changes after PEG use. This observational study compares individuals with and without prior cholecystectomy to better understand these effects. Participants include about 20 adults aged 18 to 75, split into two groups those who had cholecystectomy at least six months before and those with an intact gallbladder, matched by age and sex. All participants undergo standard colonoscopy preparation using 2 to 4 liters of PEG-based laxative, following routine clinical practice. Stool samples are self-collected at five time points before bowel preparation, at the first non-watery stool after colonoscopy, and at 1, 3, and 6 months post-colonoscopy. During the study, stool samples will be analyzed using advanced sequencing techniques to assess changes in gut microbial diversity and composition over time. Researchers will compare these changes within and between groups to see if gallbladder removal affects microbiota recovery after PEG exposure. The main measurement is gut microbial diversity across the five collection points. Safety and adherence to sample collection will be monitored, and the total participation duration spans over six months post-colonoscopy.
CONDITIONS
PEG Laxatives for Intestinal Preparation and Gut Microbiota in Cholecystectomy
P
ping h Xie
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Tongji Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (in-person)
Duration - Approximately 6 months
Participants scheduled for colonoscopy undergo standard bowel preparation with PEG-based laxatives according to routine clinical practice. Stool samples are self-collected at home at five predefined time points to assess gut microbiota changes.
5 sample collections: within 3 days before bowel preparation, first non-watery stool after colonoscopy, and at 1 month, 3 months, and 6 months post-colonoscopy
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Bo Tang, Shengpeng Li, Xin Li...
https://pubmed.ncbi.nlm.nih.gov/40819131/Ludong Tan, Feng Jia, Yahui Liu
https://pubmed.ncbi.nlm.nih.gov/40636353/Mariana Amaral Raposo, Emília Sousa Oliveira, Andrey Dos Santos...
https://pubmed.ncbi.nlm.nih.gov/38729564/Mariëtte Y M van der Wulp, Muriel Derrien, Frans Stellaard...
https://pubmed.ncbi.nlm.nih.gov/23868407/Jiezhong Chen, Avni Sali, Luis Vitetta
https://pubmed.ncbi.nlm.nih.gov/32478580/Amelia J McGuinness, Martin O'Hely, Douglas Stupart...
https://pubmed.ncbi.nlm.nih.gov/39335452/Yu Zou, Sihui Zeng, Moxian Chen...
https://pubmed.ncbi.nlm.nih.gov/37533931/Lissette Batista, Virginia Robles, Chaysavanh Manichanh...
https://pubmed.ncbi.nlm.nih.gov/35764931/Tongji Hospital
Lead Sponsor